LipoScience, Inc., a clinical diagnostic company, is engaged in the field of personalized diagnostics based on nuclear magnetic resonance NMR technology in the United States. The company’s technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and small molecule metabolites. It offers NMR LipoProfile test, which directly measures various low density lipoprotein LDL particles in a blood sample, and provides physicians and their patients with information to personalize management of risk for heart disease. LipoScience, Inc. sells its NMR LipoProfile test to clinical diagnostic laboratories, clinicians, and other healthcare professionals for use in patient care. The company was formerly known as LipoMed, Inc. and changed its name to LipoScience, Inc. in January 2002. LipoScience, Inc. was incorporated in 1994 and is headquartered in Raleigh, North Carolina. As of November 20, 2014, LipoScience, Inc. operates as a subsidiary of Laboratory Corporation of America Holdings